Indegene climbs on launching new entity in Spain
Indegene is currently trading at Rs. 624.05, up by 16.15 points or 2.66% from its previous closing of Rs. 607.90 on the BSE.
The scrip opened at Rs. 602.90 and has touched a high and low of Rs. 628.50 and Rs. 602.90 respectively. So far 13728 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 736.60 on 01-Oct-2024 and a 52 week low of Rs. 468.90 on 04-Jun-2024.
Last one week high and low of the scrip stood at Rs. 632.00 and Rs. 592.00 respectively. The current market cap of the company is Rs. 14936.59 crore.
The Institutions and Non-Institutions held 9.00% and 91.00%, stake in the company respectively.
Indegene has launched a new entity in Spain. This move marks a key step in the company’s ongoing strategic expansion in Europe and aligns with the company’s commitment to helping life sciences companies accelerate AI-driven innovation and make their operations future-ready.
The company’s new Spain entity will serve as a key delivery hub for its Europe-based clients, helping them drive hyper-personalization and significantly elevate HCP and patient experience. The company is strengthening its already existing employee base in Spain, with capabilities in medical affairs, data and analytics, creative design, engineering, digital marketing and customer experience.
Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products.
